Recombinant birnavirus vaccine

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 7/01 (2006.01) A61K 39/12 (2006.01) A61K 39/15 (2006.01) C12N 7/00 (2006.01) C12N 7/04 (2006.01) C12N 15/33 (2006.01) C12N 15/40 (2006.01) C12N 15/86 (2006.01) G01N 33/50 (2006.01) G01N 33/569 (2006.01)

Patent

CA 2238659

The present invention provides a birnavirus mutant which is suited as vaccine candidate in eradication control programmes. The mutant is not able to produce a native VP5 protein, and this feature can be used as a marker to distinguish between animals vaccinated with the VP5 mutant or infected with a naturally-occurring birnavirus.

La présente invention porte sur un mutant du birnavirus qui peut être utilisé comme candidat- vaccin dans le cadre de programmes d'éradication de maladies. Le mutant est incapable de produire une protéine native du gène VP5, et cette caractéristique peut être utilisée comme marqueur afin de distinguer les animaux vaccinés avec le mutant du gène VP5 des animaux infectés par un birnavirus naturel.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Recombinant birnavirus vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Recombinant birnavirus vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant birnavirus vaccine will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1714424

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.